인슐린 시장

Insulin Market- Scope of Report

TMR's report on the global Insulin Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Insulin Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Insulin Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Insulin Market .

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Insulin Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Insulin Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Insulin Market .

The report delves into the competitive landscape of the global Insulin Market. Key players operating in the global Insulin Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Insulin Market profiled in this report.

Key Questions Answered in Global Insulin Market Report:

• What are the opportunities in the global Insulin Market ?
• What are the major drivers, restraints, opportunities, and threats in the Market ?
• Which regional Market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the Market positions of different companies operating in the global Market ?

Insulin Market- Research Objectives and Research Approach

The comprehensive report on the global Insulin Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Insulin Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Insulin Market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Insulin Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Insulin Market Analysis and Forecasts, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Key Industry Events
• 5.2. Epidemiology by Key Countries/Regions
• 5.3. Supply Chain Analysis
• 5.4. Technological advancements
• 5.5. Regulatory Scenario by Key Countries/Regions
• 5.6. Go-to Market Strategy
• 5.7. End-user Preference
• 5.8. Reimbursement Scenario by Key Countries
• 5.9. Top 10 Players Operating In the Market Space- Global
• 5.10. Key Product/Brand Analysis
• 5.11. Porter's Five Forces Analysis
• 5.12. PESTLE Analysis
• 5.13. Benchmarking of Products offered by Competitors

6. Global Insulin Market Analysis and Forecasts, By Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product Type, 2020 to 2035
  • 6.3.1. Rapid-acting insulin
  • 6.3.2. Short-acting insulin
  • 6.3.3. Intermediate-acting insulin
  • 6.3.4. Long-acting insulin
  • 6.3.5. Biphasic insulin
• 6.4. Market Attractiveness By Product Type

7. Global Insulin Market Analysis and Forecasts, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2020 to 2035
  • 7.3.1. Type 1 Diabetes
  • 7.3.2. Type 2 Diabetes
  • 7.3.3. Gestational Diabetes
• 7.4. Market Attractiveness By Application

8. Global Insulin Market Analysis and Forecasts, By Delivery Device

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Delivery Device, 2020 to 2035
  • 8.3.1. Pens
  • 8.3.2. Insulin Pumps
  • 8.3.3. Syringes
  • 8.3.4. Jets
• 8.4. Market Attractiveness By Delivery Device

9. Global Insulin Market Analysis and Forecasts, By Source

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Source, 2020 to 2035
  • 9.3.1. Human Insulin
  • 9.3.2. Insulin Analog
• 9.4. Market Attractiveness By Source

10. Global Insulin Market Analysis and Forecasts, By Distribution Channel

• 10.1. Introduction & Definition
• 10.2. Key Findings / Developments
• 10.3. Market Value Forecast By Distribution Channel, 2020 to 2035
  • 10.3.1. Hospital Pharmacies
  • 10.3.2. Retail Pharmacies
  • 10.3.3. Online Pharmacies
• 10.4. Market Attractiveness By Distribution Channel

11. Global Insulin Market Analysis and Forecasts, By Region

• 11.1. Key Findings
• 11.2. Market Value Forecast By Region
  • 11.2.1. North America
  • 11.2.2. Europe
  • 11.2.3. Asia Pacific
  • 11.2.4. Latin America
  • 11.2.5. Middle East & Africa
• 11.3. Market Attractiveness By Region

12. North America Insulin Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product Type, 2020 to 2035
  • 12.2.1. Rapid-acting insulin
  • 12.2.2. Short-acting insulin
  • 12.2.3. Intermediate-acting insulin
  • 12.2.4. Long-acting insulin
  • 12.2.5. Biphasic insulin
• 12.3. Market Value Forecast By Application, 2020 to 2035
  • 12.3.1. Type 1 Diabetes
  • 12.3.2. Type 2 Diabetes
  • 12.3.3. Gestational Diabetes
• 12.4. Market Value Forecast By Delivery Device, 2020 to 2035
  • 12.4.1. Pens
  • 12.4.2. Insulin Pumps
  • 12.4.3. Syringes
  • 12.4.4. Jets
• 12.5. Market Value Forecast By Source, 2020 to 2035
  • 12.5.1. Human Insulin
  • 12.5.2. Insulin Analog
• 12.6. Market Value Forecast By Distribution Channel, 2020 to 2035
  • 12.6.1. Hospital Pharmacies
  • 12.6.2. Retail Pharmacies
  • 12.6.3. Online Pharmacies
• 12.7. Market Value Forecast By Country, 2020 to 2035
  • 12.7.1. U.S.
  • 12.7.2. Canada
• 12.8. Market Attractiveness Analysis
  • 12.8.1. By Product Type
  • 12.8.2. By Application
  • 12.8.3. By Delivery Device
  • 12.8.4. By Source
  • 12.8.5. By Distribution Channel
  • 12.8.6. By Country

13. Europe Insulin Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product Type, 2020 to 2035
  • 13.2.1. Rapid-acting insulin
  • 13.2.2. Short-acting insulin
  • 13.2.3. Intermediate-acting insulin
  • 13.2.4. Long-acting insulin
  • 13.2.5. Biphasic insulin
• 13.3. Market Value Forecast By Application, 2020 to 2035
  • 13.3.1. Type 1 Diabetes
  • 13.3.2. Type 2 Diabetes
  • 13.3.3. Gestational Diabetes
• 13.4. Market Value Forecast By Delivery Device, 2020 to 2035
  • 13.4.1. Pens
  • 13.4.2. Insulin Pumps
  • 13.4.3. Syringes
  • 13.4.4. Jets
• 13.5. Market Value Forecast By Source, 2020 to 2035
  • 13.5.1. Human Insulin
  • 13.5.2. Insulin Analog
• 13.6. Market Value Forecast By Distribution Channel, 2020 to 2035
  • 13.6.1. Hospital Pharmacies
  • 13.6.2. Retail Pharmacies
  • 13.6.3. Online Pharmacies
• 13.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 13.7.1. Germany
  • 13.7.2. U.K.
  • 13.7.3. France
  • 13.7.4. Italy
  • 13.7.5. Spain
  • 13.7.6. Switzerland
  • 13.7.7. The Netherlands
  • 13.7.8. Rest of Europe
• 13.8. Market Attractiveness Analysis
  • 13.8.1. By Product Type
  • 13.8.2. By Application
  • 13.8.3. By Delivery Device
  • 13.8.4. By Source
  • 13.8.5. By Distribution Channel
  • 13.8.6. By Country/Sub-region

14. Asia Pacific Insulin Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product Type, 2020 to 2035
  • 14.2.1. Rapid-acting insulin
  • 14.2.2. Short-acting insulin
  • 14.2.3. Intermediate-acting insulin
  • 14.2.4. Long-acting insulin
  • 14.2.5. Biphasic insulin
• 14.3. Market Value Forecast By Application, 2020 to 2035
  • 14.3.1. Type 1 Diabetes
  • 14.3.2. Type 2 Diabetes
  • 14.3.3. Gestational Diabetes
• 14.4. Market Value Forecast By Delivery Device, 2020 to 2035
  • 14.4.1. Pens
  • 14.4.2. Insulin Pumps
  • 14.4.3. Syringes
  • 14.4.4. Jets
• 14.5. Market Value Forecast By Source, 2020 to 2035
  • 14.5.1. Human Insulin
  • 14.5.2. Insulin Analog
• 14.6. Market Value Forecast By Distribution Channel, 2020 to 2035
  • 14.6.1. Hospital Pharmacies
  • 14.6.2. Retail Pharmacies
  • 14.6.3. Online Pharmacies
• 14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 14.7.1. China
  • 14.7.2. India
  • 14.7.3. Japan
  • 14.7.4. South Korea
  • 14.7.5. Australia & New Zealand
  • 14.7.6. Rest of Asia Pacific
• 14.8. Market Attractiveness Analysis
  • 14.8.1. By Product Type
  • 14.8.2. By Application
  • 14.8.3. By Delivery Device
  • 14.8.4. By Source
  • 14.8.5. By Distribution Channel
  • 14.8.6. By Country/Sub-region

15. Latin America Insulin Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product Type, 2020 to 2035
  • 15.2.1. Rapid-acting insulin
  • 15.2.2. Short-acting insulin
  • 15.2.3. Intermediate-acting insulin
  • 15.2.4. Long-acting insulin
  • 15.2.5. Biphasic insulin
• 15.3. Market Value Forecast By Application, 2020 to 2035
  • 15.3.1. Type 1 Diabetes
  • 15.3.2. Type 2 Diabetes
  • 15.3.3. Gestational Diabetes
• 15.4. Market Value Forecast By Delivery Device, 2020 to 2035
  • 15.4.1. Pens
  • 15.4.2. Insulin Pumps
  • 15.4.3. Syringes
  • 15.4.4. Jets
• 15.5. Market Value Forecast By Source, 2020 to 2035
  • 15.5.1. Human Insulin
  • 15.5.2. Insulin Analog
• 15.6. Market Value Forecast By Distribution Channel, 2020 to 2035
  • 15.6.1. Hospital Pharmacies
  • 15.6.2. Retail Pharmacies
  • 15.6.3. Online Pharmacies
• 15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 15.7.1. Brazil
  • 15.7.2. Mexico
  • 15.7.3. Argentina
  • 15.7.4. Rest of Latin America
• 15.8. Market Attractiveness Analysis
  • 15.8.1. By Product Type
  • 15.8.2. By Application
  • 15.8.3. By Delivery Device
  • 15.8.4. By Source
  • 15.8.5. By Distribution Channel
  • 15.8.6. By Country/Sub-region

16. Middle East & Africa Insulin Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast By Product Type, 2020 to 2035
  • 16.2.1. Rapid-acting insulin
  • 16.2.2. Short-acting insulin
  • 16.2.3. Intermediate-acting insulin
  • 16.2.4. Long-acting insulin
  • 16.2.5. Biphasic insulin
• 16.3. Market Value Forecast By Application, 2020 to 2035
  • 16.3.1. Type 1 Diabetes
  • 16.3.2. Type 2 Diabetes
  • 16.3.3. Gestational Diabetes
• 16.4. Market Value Forecast By Delivery Device, 2020 to 2035
  • 16.4.1. Pens
  • 16.4.2. Insulin Pumps
  • 16.4.3. Syringes
  • 16.4.4. Jets
• 16.5. Market Value Forecast By Source, 2020 to 2035
  • 16.5.1. Human Insulin
  • 16.5.2. Insulin Analog
• 16.6. Market Value Forecast By Distribution Channel, 2020 to 2035
  • 16.6.1. Hospital Pharmacies
  • 16.6.2. Retail Pharmacies
  • 16.6.3. Online Pharmacies
• 16.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
  • 16.7.1. GCC Countries
  • 16.7.2. South Africa
  • 16.7.3. Rest of Middle East & Africa
• 16.8. Market Attractiveness Analysis
  • 16.8.1. By Product Type
  • 16.8.2. By Application
  • 16.8.3. By Delivery Device
  • 16.8.4. By Source
  • 16.8.5. By Distribution Channel
  • 16.8.6. By Country/Sub-region

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 17.2. Market Share Analysis By Company (2024)
• 17.3. Company Profiles
  • 17.3.1. Shanghai Fosun Pharmaceutical Co., Ltd.
    • 17.3.1.1. Company Overview
    • 17.3.1.2. Financial Overview
    • 17.3.1.3. Financial Overview
    • 17.3.1.4. Business Strategies
    • 17.3.1.5. Recent Developments
  • 17.3.2. Tonghua Dongbao
    • 17.3.2.1. Company Overview
    • 17.3.2.2. Financial Overview
    • 17.3.2.3. Financial Overview
    • 17.3.2.4. Business Strategies
    • 17.3.2.5. Recent Developments
  • 17.3.3. Eli Lilly and Company
    • 17.3.3.1. Company Overview
    • 17.3.3.2. Financial Overview
    • 17.3.3.3. Financial Overview
    • 17.3.3.4. Business Strategies
    • 17.3.3.5. Recent Developments
  • 17.3.4. Sanofi
    • 17.3.4.1. Company Overview
    • 17.3.4.2. Financial Overview
    • 17.3.4.3. Financial Overview
    • 17.3.4.4. Business Strategies
    • 17.3.4.5. Recent Developments
  • 17.3.5. Novo Nordisk A/S
    • 17.3.5.1. Company Overview
    • 17.3.5.2. Financial Overview
    • 17.3.5.3. Financial Overview
    • 17.3.5.4. Business Strategies
    • 17.3.5.5. Recent Developments
  • 17.3.6. Julphar
    • 17.3.6.1. Company Overview
    • 17.3.6.2. Financial Overview
    • 17.3.6.3. Financial Overview
    • 17.3.6.4. Business Strategies
    • 17.3.6.5. Recent Developments
  • 17.3.7. Biocon Ltd.
    • 17.3.7.1. Company Overview
    • 17.3.7.2. Financial Overview
    • 17.3.7.3. Financial Overview
    • 17.3.7.4. Business Strategies
    • 17.3.7.5. Recent Developments
  • 17.3.8. Becton, Dickinson, and Company
    • 17.3.8.1. Company Overview
    • 17.3.8.2. Financial Overview
    • 17.3.8.3. Financial Overview
    • 17.3.8.4. Business Strategies
    • 17.3.8.5. Recent Developments
  • 17.3.9. Ypsomed AG
    • 17.3.9.1. Company Overview
    • 17.3.9.2. Financial Overview
    • 17.3.9.3. Financial Overview
    • 17.3.9.4. Business Strategies
    • 17.3.9.5. Recent Developments
  • 17.3.10. Biodel, Inc.
    • 17.3.10.1. Company Overview
    • 17.3.10.2. Financial Overview
    • 17.3.10.3. Financial Overview
    • 17.3.10.4. Business Strategies
    • 17.3.10.5. Recent Developments
  • 17.3.11. B. Braun Melsungen AG
    • 17.3.11.1. Company Overview
    • 17.3.11.2. Financial Overview
    • 17.3.11.3. Financial Overview
    • 17.3.11.4. Business Strategies
    • 17.3.11.5. Recent Developments